Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Veracyte Inc (NQ: VCYT ) 29.77 UNCHANGED Streaming Delayed Price Updated: 4:00 PM EDT, Sep 5, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Veracyte Inc < Previous 1 2 3 4 5 6 7 8 9 10 Next > Veracyte to Release Third Quarter 2021 Financial Results on November 9, 2021 October 12, 2021 From Veracyte, Inc. Via Business Wire New Clinical Utility Data Confirm Veracyte’s Envisia Genomic Classifier Increases Accuracy and Confidence in IPF Diagnosis October 11, 2021 From Veracyte, Inc. Via Business Wire Veracyte Announces New Expanded Data at CHEST Underscoring Percepta Nasal Swab Test’s Ability to Improve Early Lung Cancer Assessment October 11, 2021 From Veracyte, Inc. Via Business Wire Where Veracyte Stands With Analysts August 26, 2021 Over the past 3 months, 6 analysts have published their opinion on Veracyte (NASDAQ: Via Benzinga What 9 Analyst Ratings Have To Say About Veracyte July 30, 2021 Within the last quarter, Veracyte (NASDAQ:VCYT) has observed the following... Via Benzinga Earnings Scheduled For July 29, 2021 July 29, 2021 Companies Reporting Before The Bell • Smith & Nephew (NYSE:SNN) is projected to report earnings for its second quarter. • Cohen & Co (AMEX:COHN) is... Via Benzinga New Data to be Presented at CHEST 2021 Showcase Clinical Performance of Veracyte’s Genomic Diagnostic Tests in Lung Cancer and Interstitial Lung Disease October 06, 2021 From Veracyte, Inc. Via Business Wire Is Veracyte Still a Buy After Its Recent Rally? October 05, 2021 Shares of the genetic diagnostics company are down nearly 50% from their 52-week high in February. Via The Motley Fool Biotech Playbook Revisited As Technicals Weaken September 27, 2021 Recent breakthroughs with mRNA vaccines over the past two years have shown the enormous potential for transformative therapies. DNA sequencing took off five years ago and new applications are still... Via Talk Markets Veracyte Announces that New NCCN Guidelines Uniquely Recommend Use of Decipher Prostate Genomic Test Score to Guide Specific Treatment for Men Following Radical Prostatectomy September 14, 2021 From Veracyte, Inc. Via Business Wire The Daily Biotech Pulse: Lilly, Regeneron Ink COVID-19 Drug Deal With US, Regulatory Setback For Calliditas, Theravance To Cut 75% Jobs, 4 IPOs September 15, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 14) Alcon Inc. (NYSE: ALC)... Via Benzinga Exposures COVID-19 Small Cap Biotechs Sagging But More Deals Are Likely to Perk Up the Market September 09, 2021 Despite record highs in the Nasdaq recently at the 15,000 level the biotech market seems sluggish. Speculation has ebbed. As if we need a green screen every day. Via Talk Markets Veracyte Further Strengthens Medical Team with Appointment of Joshua Klopper, M.D., as Medical Director of Endocrinology September 01, 2021 From Veracyte, Inc. Via Business Wire Veracyte to Participate in Morgan Stanley 19th Annual Global Healthcare Conference August 31, 2021 From Veracyte, Inc. Via Business Wire Vaccine Victory August 24, 2021 Monday the US stock market moved into further robust mode fueled by official FDA approval of the Pfizer and BioNTech COVID-19 vaccines. Will the momentum last through to Thursday when the Fed's Jackson... Via Talk Markets Topics Economy Exposures COVID-19 Interest Rates Product Safety Veracyte Named a San Francisco Bay Area “Top Workplace” for Eighth Consecutive Year August 23, 2021 From Veracyte, Inc. Via Business Wire 12 Health Care Stocks Moving In Friday's After-Market Session August 20, 2021 Gainers CASI Pharmaceuticals (NASDAQ:CASI Via Benzinga Veracyte Completes Acquisition of HalioDx August 03, 2021 From Veracyte Via Business Wire 12 Health Care Stocks Moving In Friday's Intraday Session July 30, 2021 Gainers Erytech Pharma (NASDAQ:ERYP) sha... Via Benzinga 63 Biggest Movers From Friday August 02, 2021 Gainers ERYTECH Pharma S.A. (NASDAQ: ERYP) shares surged 55% to close at $6.37 on Friday after the company said the FDA has granted its eryaspase fast track designation for the... Via Benzinga Exposures Product Safety 41 Stocks Moving In Friday's Mid-Day Session July 30, 2021 Gainers ERYTECH Pharma S.A. (NASDAQ: ERYP) shares jumped 90.6% to $7.84 after the company said the FDA has granted its eryaspase fast track designation for the treatment of acute... Via Benzinga Exposures Product Safety Veracyte Announces Second Quarter 2021 Financial Results July 29, 2021 From Veracyte, Inc. Via Business Wire The Daily Biotech Pulse: Merck's Disappointing Q2, Atreca Falls On Data, FDA Nod For Viatris, Nuvalent, Icosavax IPOs July 29, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 28) AbbVie Inc. (NYSE: ABBV)... Via Benzinga Exposures Product Safety After Naming a New CFO, Is This Genetic Diagnostics Company a Buy? July 29, 2021 Veracyte appointed Rebecca Chambers, who boasts a wealth of financial executive experience, to the position. Via The Motley Fool New Study Suggests Decipher Prostate Biopsy Test May Help Guide Use of Active Surveillance in Prostate Cancer July 27, 2021 From Veracyte, Inc. Via Business Wire Veracyte Appoints Rebecca Chambers as Executive Vice President and Chief Financial Officer, Further Positioning Company for Global Growth July 12, 2021 From Veracyte, Inc. Via Business Wire The Week Ahead In Biotech (July 25-31): Big Pharma Earnings, Iterum FDA Decision, Alzheimer's Conference, IPOs and More July 25, 2021 Biotech stocks rebounded in the week ended July 23, thanks to the broader market strength. The sector also benefitted from the optimism that was set in motion by the solid start... Via Benzinga Exposures Product Safety Veracyte to Release Second Quarter 2021 Financial Results on July 29, 2021 July 08, 2021 From Veracyte, Inc. Via Business Wire Veracyte Announces Key Appointments to Executive Leadership Team, Supporting Global Expansion July 08, 2021 From Veracyte, Inc. Via Business Wire Mid-Cap Biotech Picks: Seasonal Rally Underway July 03, 2021 Many Mid-Cap biotech stocks were hit hard after the February peak. We suggest three new mid-cap biotech picks. All three picks can be volatile but very tradable. Via Talk Markets < Previous 1 2 3 4 5 6 7 8 9 10 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.